Finance
UK and US poised to agree zero-tariffs deal on pharmaceuticals, The Times says
Published by Global Banking and Finance Review
Posted on December 1, 2025
1 min readLast updated: January 20, 2026
Global Banking and Finance Review
Company
Published by Global Banking and Finance Review
Posted on December 1, 2025
1 min readLast updated: January 20, 2026
The UK and US are nearing a zero-tariff pharmaceuticals deal, potentially increasing NHS medicine spending and lowering drug price rebates.
Dec 1 (Reuters) - The UK is poised to agree on a major pharmaceuticals deal with the U.S., which will mean zero import tariffs on pharmaceutical products into the U.S. and lead to an increase in NHS spending on medicines, The Times reported on Monday.
The UK government is understood to have agreed to lower an industry sales rebate rate on NHS drug prices and to also improve the NHS's cost-effectiveness measure for drugs, the report said, citing industry sources.
The British government will commit to increasing the percentage of the NHS budget that it spends on medicines, it said.
Reuters couldn't immediately verify the report.
(Reporting by Ruchika Khanna in BengaluruEditing by Bernadette Baum)
The article discusses a potential zero-tariff pharmaceuticals deal between the UK and US, which could increase NHS spending on medicines.
The NHS is expected to increase its budget for medicines and lower drug price rebate rates.
The Times reported the potential deal, citing industry sources, though Reuters could not verify it.
Explore more articles in the Finance category
